PowderB733
B7-33
Bulk≥99.5% Purity
Pharmaceutical-grade B7-33 relaxin analogue for anti-fibrotic and cardiovascular research.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
B7-33 is a single-chain peptide analogue of the B-chain of human relaxin-2. It selectively activates RXFP1, stimulating cAMP production and downstream anti-fibrotic signalling including MMP upregulation and collagen turnover, without requiring the A-chain for receptor binding.
Clinical Benefits
- Selective RXFP1 receptor activation
- Anti-fibrotic properties
- Supports cardiovascular and renal health
- Simplified single-chain structure vs native relaxin
Specifications
TargetRXFP1 receptor
Purity≥99.5% (HPLC verified)
FormBulk powder (per gram)
Storage & Handling
- Store at -20°C
- Protect from light
Related Products
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.